Company news
Quantum Cyber N.V. news in 2021
Quantum Cyber N.V.'s news releases, calls and decks from 2021, newest first.
Mainz BioMed Appoints Karen Richards as Vice President, Regulatory Affairs to Lead US FDA Approval Process
December 20, 2021
Mainz Biomed Expands ColoAlert Commercialization with GANZIMMUN Diagnostics in Europe
December 13, 2021
Mainz Biomed Launches Ecommerce Store for ColoAlert to Assist Patient Access during Covid-19 Pandemic
December 6, 2021
Mainz Biomed Establishes Partnership with Precision for Medicine to Support ColoAlert’s U.S. Regulatory and Commercial Strategy
November 29, 2021
Mainz Biomed Appoints Dr. Soren Thestrup-Nielsen M.D. to Strategic Advisory Board
November 17, 2021
Mainz Biomed to Exhibit ColoAlert at MEDICA 2021, the World’s Largest Medical Trade Fair
November 14, 2021
Mainz Biomed Appoints Former Roche Division President Heiner Dreismann to Strategic Advisory Board
November 10, 2021
Mainz Biomed Commences Trading on Nasdaq Under Ticker Symbol ‘MYNZ’
November 7, 2021
Mainz Biomed Announces Exercise of Over-Allotment Option
November 7, 2021
MYNZ Closes Its First Day of Trading on the Nasdaq Capital Market
November 4, 2021